Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion

The mechanism of skeletal myoblast fusion is not well understood. We show that endogenous nitric oxide (NO) generation is required for myoblast fusion both in embryonic myoblasts and in satellite cells. The effect of NO is concentration and time dependent, being evident only at the onset of differen...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 172; no. 2; pp. 233 - 244
Main Authors Pisconti, Addolorata, Brunelli, Silvia, Di Padova, Monica, De Palma, Clara, Deponti, Daniela, Baesso, Silvia, Sartorelli, Vittorio, Cossu, Giulio, Clementi, Emilio
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 16.01.2006
The Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The mechanism of skeletal myoblast fusion is not well understood. We show that endogenous nitric oxide (NO) generation is required for myoblast fusion both in embryonic myoblasts and in satellite cells. The effect of NO is concentration and time dependent, being evident only at the onset of differentiation, and direct on the fusion process itself. The action of NO is mediated through a tightly regulated activation of guanylate cyclase and generation of cyclic guanosine monophosphate (cGMP), so much so that deregulation of cGMP signaling leads to a fusion-induced hypertrophy of satellite-derived myotubes and embryonic muscles, and to the acquisition of fusion competence by myogenic precursors in the presomitic mesoderm. NO and cGMP induce expression of follistatin, and this secreted protein mediates their action in myogenesis. These results establish a hitherto unappreciated role of NO and cGMP in regulating myoblast fusion and elucidate their mechanism of action, providing a direct link with follistatin, which is a key player in myogenesis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-1
ObjectType-Feature-3
content type line 23
Abbreviations used in this paper: BMP, bone morphogenetic protein; CREB, cAMP response element binding protein; cGMP, cyclic guanosine mono- phosphate; DETA-NO, (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate]; E, embryonic day; Fs-luc, luciferase gene; GAPDH, glyceraldehyde3-phosphate dehydrogenase; IGF, insulin-like growth factor; IL-4, interleukin 4; l-NAME, N ω-nitro-l-arginine methyl ester; MLC1/3F, myosin light chain promoter 1/3 fast; NFAT, nuclear factor of activated T cells; NO, nitric oxide; NOS, nitric oxide synthase; ODQ, 1H-(1,2,4) oxadiazolo [4,3-α]quinoxalin-1-one; PCNA, DNA polymerase δ cofactor; PSM, presomitic mesoderm; (Rp)-8-pCPT-cGMPS, 8-(chlorophenylthio)guanosine-3′,5′- cyclic monophosphorothioate; TSA, trichostatin A.
A. Pisconti and S. Brunelli contributed equally to this paper.
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.200507083